16:34 EDT ProMIS Neurosciences (PMN) files to sell 28.23M common shares for holders
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PMN:
- Promising Outlook for ProMIS Neurosciences’ PMN310 in Alzheimer’s Treatment with Buy Rating and $3.00 Price Target
- ProMIS Neurosciences Advances Alzheimer’s Trial to Final Phase
- ProMIS receives DSMB approval to advance final dose escalation cohort
- ProMIS Neurosciences Announces At The Market Offering
- ProMIS Neurosciences: Advancements in Alzheimer’s Treatment and Strong Financial Positioning Drive Buy Rating